Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 6, 2004

View Archived Issues

Raloxifene not associated with an increase in hot flushes in postmenopausal women

Statin therapy reduces cardiovascular risk in type 2 diabetes

Boehringer Ingelheim present novel glucocorticoid receptor modulators

New NO-donating COX inhibitors claimed by Beta Pharma

Two novel series of IKK-2 inhibitors prepared and tested at AstraZeneca

AxyS (Celera Genomics) presents novel factor VIIa inhibitors

Novel BACE inhibitors in early development at De Novo

New inhibitors of Tau phosphorylation and their use described by Aventis

Long-term improvements found with sitaxsentan in PAH patients

Immunomodulatory effects of alpha-MSH in preclinical models of allergy and hypersensitivity

The Ig FLC antagonist F-991 shows promise for contact allergy

CS-747 reported to be a safe antiplatelet therapy in patients undergoing PCI

Dronedarone found to reduce the risk of recurrence of atrial fibrillation or flutter

Schering AG commences Angeliq roll-out across Europe

Cythera merges with Novocell

ReceptoPharm research into cobra venom potential for HIV

Bolder Biotechnology receives SBIR grants for oncology efforts

Cilansetron NDA accepted for priority review

Clearance sought to commence phase II trials of ThromboView in Canada

Intercell and Aventis extended bacterial vaccine collaboration

Enrollment completed in phase II/III trial of Dynavax HBV vaccine

PBI-1402 has confirmed activity on red blood cell progenitors

Company profile: Xerion

ZARS completes financing, proceeds to advance pipeline

Remoxy cleared to enter U.S. clinical studies

Icagen receives milestone payment for ICA-17043 progress

PTC Therapeutics awarded grant for Duchenne muscular dystrophy research

University of Kansas and Bioqual researchers describe a novel, orally active male contraceptive

Inhibitor of TNF-alpha converting enzyme discovered at BMS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...